<qa>  What is the dose of quetiapine in suboptimally responding patients withThis study will investigate the safety and efficacy of quetiapine in sub-optimally responding patients with DSM-IV schizophrenia using a double blind, randomized 12-week trial comparing oral doses of 1200 mgd to 600 mgd of quetiapine. 